Improving Chronic Disease Management with Pieces (ICD-Pieces)

用饮片改善慢性病管理(ICD-饮片)

基本信息

  • 批准号:
    9557797
  • 负责人:
  • 金额:
    $ 5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-09-01 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The growing number of patients who have chronic kidney disease (CKD), diabetes and hypertension is a public health challenge. CKD, diabetes and hypertension are 3 chronic medical conditions (CMCs) that increase morbidity, mortality, resource utilization and costs. Among adults in the United States the prevalence of CKD has increased from 10 to 14% over the past two decades and diabetes and hypertension are the 2 leading causes of CKD and end-stage renal disease. Important progress in identification of effective treatments for CKD, diabetes and hypertension has been made but there is a significant gap in translating these treatments to clinical practice. We have recently implemented a collaboratory primary care and nephrology care model at Parkland Health and Hospital System for patients with CKD in a predominantly minority population using a novel technology platform (Pieces- Parkland intelligent e-coordination and evaluation system) that allows us to leverage information from the electronic health record (EHR) to facilitate implementation of CKD care within primary care practices and medical homes in the community. In a study supported by NIDDK we are already observing improvements in BP control with a collaborative care model using Pieces to identify people with CKD and assist implementing recommended practices. We have also used Pieces to successfully develop various risk prediction models for readmissions and deaths in collaborating large health care systems. We now propose a randomized pragmatic trial, Improving Chronic Disease Management with Pieces (ICD-Pieces), in 4 large health care systems to test our model of care for patients with multimorbidity. The main hypothesis is that patients with CKD, hypertension and diabetes who receive care with a collaborative model of primary care-subspecialty care enhanced by novel information technology (Pieces) will have fewer hospitalizations, readmissions, CV events and deaths than patients receiving standard medical care. During the planning phase (UH2) we will establish the collaboratory and complete preparations at all participating sites for the study. In the implementation phase (UH3) we will conduct the randomized clinical trial pragmatic trial across the 4 large health care systems in the collaboratory. Our trial is pragmatic and randomized with rigorous controls and tests the implementation of several accepted and well-characterized interventions which will be coordinated and applied broadly to patients with CKD, hypertension and diabetes to evaluate clinically relevant outcomes. Our study has clearly defined milestones. The 4 participating large health care systems have different organizational structures, utilize different EHR and serve very different patient populations. We anticipate that findings from our study will provide a framework for future clinical trials and to advance the care of patients with multiple chronic medical conditions.
描述(由申请人提供):患有慢性肾脏疾病(CKD)、糖尿病和高血压的患者数量不断增加,这是一项公共卫生挑战。CKD、糖尿病和高血压是增加发病率、死亡率、资源利用和成本的3种慢性医学病症(CMC)。在美国的成人中,CKD的患病率在过去二十年中从10%增加到14%,糖尿病和高血压是CKD和终末期肾病的两个主要原因。在确定CKD、糖尿病和高血压的有效治疗方法方面取得了重要进展,但在将这些治疗方法转化为临床实践方面存在重大差距。我们最近在帕克兰健康和医院系统实施了一个合作实验室初级保健和肾脏病护理模式,用于主要为少数民族人群的CKD患者(Pieces-帕克兰智能电子协调和评估系统),使我们能够利用电子健康记录(EHR)中的信息促进在社区的初级保健实践和医疗之家实施CKD护理。在NIDDK支持的一项研究中,我们已经观察到使用Pieces的协作护理模式在BP控制方面的改善,以识别CKD患者并协助实施推荐的实践。我们还使用Pieces成功开发了各种风险预测模型,用于协作大型医疗保健系统的再入院和死亡。我们现在提出了一项随机化的实用试验,在4个大型医疗保健系统中使用碎片改善慢性病管理(ICD碎片),以测试我们对多Morphine患者的护理模式。主要假设是CKD、高血压和糖尿病患者接受由新型信息技术(Pieces)增强的初级护理-专科护理协作模式的护理,与接受标准医疗护理的患者相比,住院、再入院、CV事件和死亡较少。在计划阶段(UH 2),我们将在所有参与研究的研究中心建立合作实验室并完成准备工作。在实施阶段(UH 3),我们将在合作实验室的4个大型医疗保健系统中进行随机临床试验。我们的试验是务实的,随机的,有严格的对照,并测试了几种公认的和充分表征的干预措施的实施,这些干预措施将被协调并广泛应用于CKD,高血压和糖尿病患者,以评估临床相关的结果。我们的研究明确界定了里程碑。参与的4个大型医疗保健系统具有不同的组织结构,使用不同的EHR,并为非常不同的患者群体提供服务。我们预计,我们的研究结果将为未来的临床试验提供一个框架,并促进对多种慢性疾病患者的护理。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIGUEL A VAZQUEZ其他文献

MIGUEL A VAZQUEZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIGUEL A VAZQUEZ', 18)}}的其他基金

Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
通过降低血压目标试验 (PCOT) 预防认知能力下降
  • 批准号:
    10045903
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
通过降低血压目标试验 (PCOT) 预防认知能力下降
  • 批准号:
    10696234
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
Preventing Cognitive Decline by Reducing BP Target Trial (PCOT)
通过降低血压目标试验 (PCOT) 预防认知能力下降
  • 批准号:
    10452795
  • 财政年份:
    2020
  • 资助金额:
    $ 5万
  • 项目类别:
Improving Chronic Disease Management with Pieces (ICD-Pieces)
用饮片改善慢性病管理(ICD-饮片)
  • 批准号:
    8777866
  • 财政年份:
    2014
  • 资助金额:
    $ 5万
  • 项目类别:
Improving CKD Detection and Care in a High Risk Underserved Population
改善服务不足的高危人群的 CKD 检测和护理
  • 批准号:
    8233901
  • 财政年份:
    2011
  • 资助金额:
    $ 5万
  • 项目类别:
Improving CKD Detection and Care in a High Risk Underserved Population
改善服务不足的高危人群的 CKD 检测和护理
  • 批准号:
    8335387
  • 财政年份:
    2011
  • 资助金额:
    $ 5万
  • 项目类别:
Anatomic and functional predictors of arteriovenous fistula maturation
动静脉内瘘成熟的解剖学和功能预测因素
  • 批准号:
    7899651
  • 财政年份:
    2009
  • 资助金额:
    $ 5万
  • 项目类别:
Anatomic and functional predictors of arteriovenous fistula maturation
动静脉内瘘成熟的解剖学和功能预测因素
  • 批准号:
    8121623
  • 财政年份:
    2008
  • 资助金额:
    $ 5万
  • 项目类别:
Anatomic and functional predictors of arteriovenous fistula maturation
动静脉内瘘成熟的解剖学和功能预测因素
  • 批准号:
    7686176
  • 财政年份:
    2008
  • 资助金额:
    $ 5万
  • 项目类别:
Anatomic and functional predictors of arteriovenous fistula maturation
动静脉内瘘成熟的解剖学和功能预测因素
  • 批准号:
    7923349
  • 财政年份:
    2008
  • 资助金额:
    $ 5万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 5万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 5万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了